Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.

Life Sciences [q-bio] Microbiology and Parasitology Bacteriology Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Microbiology and Parasitology Parasitology Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system Life Sciences [q-bio] Human health and pathology Emerging diseases Life Sciences [q-bio] Human health and pathology Infectious diseases

Isabelle COMBE : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03215722

Submitted on : Monday, May 3, 2021-3:02:52 PM

Last modification on : Friday, April 1, 2022-3:45:51 AM

Dates and versions

hal-03215722 , version 1 (03-05-2021)

Identifiers

HAL Id : hal-03215722 , version 1
DOI : 10.1016/j.ijantimicag.2020.106241
PUBMEDCENTRAL : PMC7779257

Cite

Philippe Gautret, van Thuan Hoang, Stéphane Honoré, Yanis Roussel, Matthieu Million, et al.. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.. International Journal of Antimicrobial Agents, 2021, 57 (1), pp.106241. ⟨10.1016/j.ijantimicag.2020.106241⟩. ⟨hal-03215722⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU INCIAM

11 View

0 Download